罗欣药业 (002793)

Luoxin Pharmaceuticals Group Stock Co., Ltd.

ASZ

Tags

Generic DrugsChemical PharmaceuticalsPrivate Placement ProposalsHelicobacter PyloriSmart HealthcareNew Private Equity HoldingsPrivate Equity Heavy PositionsCNI Private Placement IndexSZSE Medicine Equal Weight IndexShenzhen A-Share Pharmaceutical IndexSZSE 700 IndexSZSE 1000 IndexNew Virus PreventionRestructuringCOVID-19 PreventionSME Board Composite IndexSZSE Selected IndexSME Board Innovation IndexZhongchuang 400 IndexZhejiangShandong

K-Line Chart

No K-line data available

Company NameLuoxin Pharmaceutical Group Co., Ltd.
Listing Date2016-04-15
Issue Price11.97RMB
Registered Capital108758.848610k RMB
Legal RepresentativeLiu Zhenteng
Registered AddressBuilding 4, No. 18 Luoqi Road, Luozhuang District, Linyi City, Shandong Province
IndustryChemical Pharmaceuticals
Main BusinessResearch, development, production, and sales of pharmaceutical products
Company ProfileZhejiang Dongyin Pump Industry Co., Ltd. was founded in 1993, with a current registered capital of 100 million yuan. It specializes in the research, development, production, and sales of submersible well pumps, small submersible pumps, and surface pumps. As a high-tech enterprise, Dongyin has now joined the ranks of the world's leading pump manufacturers. Its product portfolio includes over 40 series and more than 2,000 models, widely used in agricultural and forestry irrigation, domestic water supply, industrial water use, pumping station water lifting, municipal engineering, building water supply, sewage/clean water treatment, and other fields.

Stock Details

1. Key Indicators

  • Total Shares(W): 108758.85
  • Circulating A-Shares(W): 108593.53
  • Earnings Per Share(RMB): 0.0216
  • Net Assets Per Share(RMB): 1.3355
  • Operating Revenue(W RMB): 172341.52
  • Total Profit(W RMB): 5131.89
  • Net Profit Attributable to Parent(W RMB): 2292.68
  • Net Profit Growth Rate(%): 108.64
  • Weighted Return on Equity(%): 1.62
  • Operating Cash Flow Per Share(RMB): 0.2580
  • Undistributed Profit Per Share(RMB): -0.0619
  • Capital Reserve Per Share(RMB): 0.3674

2. Main Business

The main business covers:

  • Research, production and sales of pharmaceutical products

3. Company Basic Information

  • Company Name: Luoxin Pharmaceuticals Group Stock Co., Ltd.
  • Listing Date: 2016-04-15
  • Industry: Pharmaceutical Manufacturing
  • Address: 4th Building, No.18 Luoqi Road, Luozhuang District, Linyi City, Shandong Province; 7th Floor, Building A, Phase I, Qian Tan Shi Mao Center, No. 255 Dongyu Road, Pudong New District, Shanghai
  • Website: www.luoxin.cn
  • Company Profile: The company was established through the overall change of Dongyin Co., Ltd. On May 28, 2012, approved by the first shareholders' meeting, the original shareholders of Dongyin Co., Ltd. acted as promoters, converting the audited net assets of 151,869,296.72 yuan as of December 31, 2011 into 75 million shares, with a par value of 1 yuan per share. The excess of net assets over share capital, 76,869,296.72 yuan, was recorded as capital reserve. Dongyin Co., Ltd. was wholly transformed into a joint stock company. Tianjian Certified Public Accountants verified the receipt of the registered capital at the time of the overall change and issued the "Tianjian Yan (2012) No. 153" "Capital Verification Report". On June 7, 2012, Dongyin Pump Industry completed the industrial and commercial registration procedures at the Taizhou Administration for Industry and Commerce and obtained the "331081100011767" "Business License of Enterprise Legal Person" with a registered capital of 75 million yuan.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Shandong Luoxin Holding Co., Ltd. General Legal Person 23695.55 21.82
2 Shanghai Zhongjue Private Fund Management Co., Ltd. - Zhongjue Zhongju Zengli No.1 Private Securities Investment Fund Private Securities Investment Fund 5437.94 5.01
3 ALLY BRIDGE FLAGSHIP LX(HK)LIMITED General Legal Person 4660.95 4.29
4 Hong Kong Securities Clearing Company Ltd. Northbound Funds 3033.83 2.79
5 Karamay Deyi Xinhua Equity Investment Limited Partnership General Legal Person 2496.14 2.30
6 Deyi Investment Management (Beijing) Co., Ltd. - Chengdu Deyi Xinhua Equity Investment Partnership (Limited Partnership) General Legal Person 2310.27 2.13
7 Luoxin Pharmaceuticals Group Stock Co., Ltd. - 2024 Employee Stock Ownership Plan Asset Management Plan 1821.95 1.68

5. Concept Sectors

  • Private Hospital
  • Smart Healthcare
  • Generic Drugs
  • Helicobacter Pylori
  • Innovative Drugs
  • Private Placement Plan
  • Consecutive Losses
  • Equity Transfer
  • New Private Placement Entry
  • Heavy Private Placement Holdings

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information